Connect with us

Uncategorized

3 Major European Cannabis Markets That Could Boom In 2021

2020 was a challenging year for the global economy and countries are looking to find new taxable revenue streams to bounce back from the COVID pandemic. During the early months of the pandemic, the European Union (EU) was considered to be a hot spot for the pandemic and countries adopted lockdown measures to slow down […]

The post 3 Major European Cannabis Markets That Could Boom In 2021 appeared first on Technical420.

Republished by Plato

Published

on

2020 was a challenging year for the global economy and countries are looking to find new taxable revenue streams to bounce back from the COVID pandemic.

During the early months of the pandemic, the European Union (EU) was considered to be a hot spot for the pandemic and countries adopted lockdown measures to slow down the spreading of the virus.

We expect the cannabis industry to continue to be a beneficiary of the COVID pandemic and believe that additional countries in the EU will pass cannabis legislation in an effort to bring in additional taxable revenue.

The last few years have been significant for the cannabis industry in the EU and this is a trend that we expect to continue. We believe the EU cannabis industry is barely in the first inning of a major growth cycle and are of the opinion that the COVID pandemic will serve as a catalyst for growth for the entire market.

Today, we have highlighted 3 EU cannabis markets that are expected to report strong growth in 2021, as well as some of the companies that are levered to these opportunities. We believe these markets are strategic in nature as they provide businesses with a launch pad into additional markets in the EU.

Is 2021 the Year for Recreational Cannabis in Germany?

Germany is the largest cannabis market is the EU and we are favorable on the long-term growth prospects that are associated with it. Although we have been bullish on the German cannabis opportunity, the market has been slow to advance and this negatively impacted the Canadian Licensed Producers (LPs) that were early movers on it.

From Canopy Growth Corporation (WEED.TO) (CGC) to Aurora Cannabis Inc. (ACB.TO) (ACB), several of the largest Canadian LPs were early movers on the German cannabis market. For operators of this size, the slow advancement of the market was not as significant. For smaller operators, most of their respective resources were invested in Germany and the lack of advancement served as a huge headwind for growth.

This year, we expect to see companies report increasing revenue from the German medical cannabis market. The biggest potential catalyst for the German cannabis market would be the passing of recreational cannabis legislation. We believe the COVID pandemic has made legal recreational cannabis in German more of a possibility and will continue to closely monitor this emerging market.

United Kingdom’s Cannabis Market is Just Getting Started

The United Kingdom (UK) is an emerging cannabis market and was home base for GW Pharmaceuticals plc (GWPH) for more than a decade. While GW is a biotech company that is focused on developing and commercializing cannabis-based treatments, the UK cannabis industry has evolved over the last few years.

The Medical Cannabis Clinics (TMCC) is considered to be an emerging leader in the UK’s cannabis industry. The company is led by 25 doctors that specialize in prescribing medical cannabis to patients

TMCC recently announced a major milestone and reported to be prescribing medical cannabis for more than 1,500 patients. These patients are having their orders fulfilled by Dispensary Green, which is owned by LYPHE Group and we find this to be significant.

According to a press release, there are approx. 2,500 cannabis patients in the UK (in 2020). Based on this statistic TMCC has a 60% market share of the UK’s cannabis market and this is a metric that we find to be significant. With approx. 40% of patients coming from London, the city has turned into a hotspot for the cannabis industry and we will monitor how it evolves this year.

According to New Frontier Data, the two biggest CBD markets in the EU are Germany and the United Kingdom (UK). These two markets account for approx. $2.17 billion (USD) and $2.03 billion (USD), respectively, in annual spending for 2020. We will monitor how these number translate over to tetrahydrocannabinol (THC) over the long term.

Poland: A Market to be Aware of

Poland is an emerging cannabis market in the EU and is one of the continents largest CBD market. A few months ago, Hemp Industry Daily published data on the Polish CBD market and we were impressed with how the industry has advanced in such a short period of time.

When compared to 2019, Polish farmers have almost doubled the amount of acreage that is being used to cultivate hemp so far this year. During the last year, Poland developed a reputation as a primary hub in the EU for processing CBD. The reputation was formed due to the growth of small extraction operations and this is a market that we are bullish on.

According to official data, Polish hemp farmers cultivated at least 7,480 acres in 2019 which represents an increase of 79% when compared to 2018. The figure is based on the area that was declared by farmers who received an EU subsidy.

We believe that the Polish CBD industry is expected to continue to record strong growth. The size of the market has steadily increased since 2015 (based on the number of hectares of hemp that is being cultivated) and this is trend that caught our attention. Like the UK, we are interested in seeing how the CBD market translates over to the THC market over the long-term.

Share Share - Facebook Share - Twitter

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Source: https://technical420.com/cannabis-article/3-major-european-cannabis-markets-that-could-boom-in-2021/

Uncategorized

Canopy Rivers Sets Filing Date For Q3 Fiscal Year 2021 Financial Results

Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) will report its third quarter fiscal year 2021 financial results before markets open on February 10, 2021 . The Company’s unaudited condensed interim consolidated financial statements and management’s discussion and analysis of financial results for the three and nine months ended December 31, 2020 will be available on […]

The post Canopy Rivers Sets Filing Date For Q3 Fiscal Year 2021 Financial Results appeared first on Technical420.

Republished by Plato

Published

on

Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) will report its third quarter fiscal year 2021 financial results before markets open on February 10, 2021 . The Company’s unaudited condensed interim consolidated financial statements and management’s discussion and analysis of financial results for the three and nine months ended December 31, 2020 will be available on the Company’s profile on the System for Electronic Document Analysis and Retrieval at www.sedar.com and on the Company’s website atwww.canopyrivers.com/investors .

Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX: WEED, NYSE: CGC), which are currently scheduled to be released on February 9, 2021 .

Following the release of its third quarter fiscal year 2021 financial results, Canopy Rivers will host a conference call and audio webcast with Narbe Alexandrian, President and CEO, Eddie Lucarelli , CFO, and Matt Mundy , Chief Strategy Officer and General Counsel, at 9 AM Eastern Time on February 10, 2021 .

Webcast
A live audio webcast will be available at the below address: https://produceredition.webcasts.com/starthere.jsp?ei=1420788&tp_key=9086023c9b .

Telephone
North American toll free dial-in: 1-888-390-0546
Confirmation #: 18291365

Replay Options
A replay of call will be accessible until February 17, 2021 .
Replay dial-in: 1-888-390-0541
Replay entry code: 291365 #

About Canopy Rivers
Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 17 companies across various segments of the cannabis value chain. We believe that bringing together people, capital, and ideas raises the potential of the entire cannabis industry. By leveraging our industry insights, in-house expertise, and thesis-driven approach to investing, we aim to provide shareholders with exposure to specialized and disruptive cannabis companies. Our mission is to invest in innovators across the cannabis value chain, help them grow, and ultimately create value by guiding these companies towards a monetization event. Together with our portfolio, we are helping build the cannabis industry of tomorrow, today.

Forward Looking Statements
This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Canopy Rivers with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding the timing and availability of the financial results of the Company and Canopy Growth Corporation and the Company’s earnings call.

Investors are cautioned that forward-looking information is not based on historical fact but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Canopy Rivers believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of Canopy Rivers. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; changes in cannabis industry growth and trends; changes in general economic, business and political conditions, including challenging global financial conditions and the impact of the novel coronavirus pandemic; potential conflicts of interest; the regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; risks associated with the termination, renegotiation and enforcement of material contracts; credit, liquidity and additional financing risks; changes in applicable laws; compliance with extensive government regulation, including Canopy Rivers’ interpretation of such regulation; public opinion and perception of the cannabis industry; divestiture risks; competition risks; and the risk factors set out in Canopy Rivers’ annual information form dated June 2, 2020 , filed with the Canadian securities regulators and available on Canopy Rivers’ profile on SEDAR at www.sedar.com .

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Canopy Rivers has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Canopy Rivers does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Cision

View original content to download multimedia: http://www.prnewswire.com/news-releases/canopy-rivers-sets-filing-date-for-q3-fiscal-year-2021-financial-results-301215527.html

SOURCE Canopy Rivers Inc.

Source: https://technical420.com/cannabis-article/canopy-rivers-sets-filing-date-for-q3-fiscal-year-2021-financial-results/

Continue Reading

Uncategorized

Innovative Industrial Properties Closes Major Acquisition In The Sunshine State

The cannabis real estate market is heating up and Innovative Industrial Properties, Inc. (IIPR) has been one of the main beneficiaries of this trend. The company is the only cannabis focused real estate investment trust (REIT) to trade on the New York Stock Exchange (NYSE) and we are impressed with the way the story has […]

The post Innovative Industrial Properties Closes Major Acquisition In The Sunshine State appeared first on Technical420.

Republished by Plato

Published

on

The cannabis real estate market is heating up and Innovative Industrial Properties, Inc. (IIPR) has been one of the main beneficiaries of this trend. The company is the only cannabis focused real estate investment trust (REIT) to trade on the New York Stock Exchange (NYSE) and we are impressed with the way the story has advanced over the last two years.

From a merger and acquisition (M&A) standpoint, Innovative Industrial Properties has been nothing short of an execution story and has been making acquisitions at a very fast pace. The company is clearly trying to take advantage of its first mover advantage before additional cannabis REITs come to market and we will be closely monitoring this trend.

Earlier this week, Innovative Industrial Properties completed the acquisition of a property in Alachua, Florida, which comprises approximately 295,000 sq. ft. of industrial space. The purchase price for the property was $23.8 million (excluding transaction costs) and the company has agreed to provide reimbursement of up to approx. $10.8 million.

Florida is attractive cannabis market and we are favorable on the leverage the cannabis REIT has to the market. During the last year, the number of medical cannabis patients in Florida has steadily increased and this is a trend that we expect to become more significant over the coming years.

In the next few years, we expect Florida to legalize recreational cannabis and expect companies like Innovative Industrial Properties to benefit from the continued advancement of the market. Going forward, we expect to see the company announce additional acquisitions of real estate in Florida and will keep an eye on this trend.

As of January 25th, Innovative Industrial Properties reported to own 67 properties (Arizona, California, Colorado, Florida, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New York, North Dakota, Ohio, Pennsylvania, Virginia and Washington) that have approx. 5.7 million rentable square feet (including approximately 2.1 million rentable square feet under development/redevelopment). The properties are 100% leased with a weighted-average remaining lease term of approximately 16.6 years.

We find these numbers to be attractive and expect Innovative Industrial Properties to continue to acquire properties at a rapid pace. When it comes to raising capital, the company has had no issues and Wall Street seems to be very willing to lend money to the business. Innovative Industrial Properties has used Wall Street to fund its acquisition strategy and we expect this trend to continue.

If you are interested in learning more about Innovative Industrial Properties, please send an email to support@technical420.com with the subject “Innovative Industrial Properties” to be added to our distribution list.

Share Share - Facebook Share - Twitter

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Source: https://technical420.com/cannabis-article/innovative-industrial-properties-closes-major-acquisition-in-the-sunshine-state/

Continue Reading

Uncategorized

AGP Gets Bullish On The Cannabis Sector With Numerous Price Target Upgrades

Earlier this week, Alliance Global Partners reported eight price target increases on Canadian and US cannabis companies and this is a development that caught our attention.  From a breadth standpoint, we are favorable on the increases that were reported by the broker-dealer. The companies that were selected are diverse and we believe that this bodes […]

The post AGP Gets Bullish On The Cannabis Sector With Numerous Price Target Upgrades appeared first on Technical420.

Republished by Plato

Published

on

Earlier this week, Alliance Global Partners reported eight price target increases on Canadian and US cannabis companies and this is a development that caught our attention. 

From a breadth standpoint, we are favorable on the increases that were reported by the broker-dealer. The companies that were selected are diverse and we believe that this bodes well for the entire industry. 

Today, we want to highlight 5 of the increases that were reported by Alliance Global Partners and believe that our readers need to be aware of the bank’s bullish view on the cannabis industry:

  1. KushCo Holdings Inc. (KSHB) had its price target raised to $2.50 from $2.00 (USD)
  2. Tilray Inc. (TLRY) had its price target raised to $18 from $10 (USD)
  3. Canopy Growth Corp. (WEED.TO) (CGC) had its price target raised to $41 from $32 (CAD)
  4. Village Farms Intl. (VFF.TO) (VFF) had its price target raised to $24 from $16 (CAD)
  5. HEXO Corp. (HEXO.TO) (HEXO) had its price target raised to $9.50 from $1.75 (CAD)

We are favorable on the upgrades that were reported by Alliance Global Partners and will monitor how the bank’s view opinion on the cannabis sector changes throughout the year. We believe the cannabis companies that were upgraded are quality plays on the legalization trend that is taking place on the global stage. 

Over the next year, we expect to see more broker-dealers follow a path that is similar to Alliance Global Partners as it relates to price target hikes. Wall Street banks tend to operate in a heard like mentality and expect to see other banks issues price target increases on the cannabis sector. 

Download Our Report On This Canadian LP Flying Under The Radar

The developments that are taking place in the US as it relates to cannabis legalization are expected to play a key role in the performance of the industry. Wall Street seems to be pricing in cannabis decriminalization in the US and we believe this would prove to be a game-changer for the entire sector. 

If you are interested in learning more about the banks that are covering the US and Canadian cannabis industry, please send an email to suppot@technical420.com with the subject “US and Canadian Cannabis Industry” to be added to our distribution list. 

Share Share - Facebook Share - Twitter

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Source: https://technical420.com/cannabis-article/agp-goes-bullish-on-the-cannabis-sector-with-numerous-price-target-upgrades/

Continue Reading
News2 days ago

Cansortium Inc. Appoints CEO Robert Beasley to Board of Directors

Heartland4 days ago

Looking for something similar to FEALS but less pricey.

Heartland2 days ago

is it possible for accidental thc product in my cbd cigarettes?

News5 days ago

Florida Lawmakers Pushing For Cannabis Law Changes And Reform

Heartland5 days ago

My new ‘Up in Smoke’ 40th Anniversary Rolling Tray! 🌱🎱😎 Love it! High Quality and Much Larger than Anticipated!

Heartland4 days ago

Anyone had issues ordering from the US to the uk

Heartland1 day ago

Can cbd help prevent hearing loss due to noise?

Heartland1 day ago

Plant Power: Everyday Plants That Activate the Endocannabinoid System

Heartland1 day ago

A good oil based sweetener?

Heartland4 days ago

Newbie questions regarding cbd & anxiety

Heartland4 days ago

1 dropper CBD VS 2 droppers CBD = dramatic contrast in effect

Heartland5 days ago

Quitting Nicotine

Heartland5 days ago

Anyone heard of or have tried this brand? Location near Dallas Texas

Heartland4 days ago

CBD oil causing issues with heart

Heartland5 days ago

Horizons ETFs to Launch World’s First Psychedelics-Focused ETF

Heartland23 hours ago

Build up of yellowy gold stuff inside vape tank. Is this the CBD content getting stuck? Can I extract it and dissolve it back into the E liquid?

Uncategorized5 days ago

USDA Final Rule on Hemp

Heartland5 days ago

What Is Kief And How To Use It | Honest Marijuana

Heartland5 days ago

CBG is so amazing for me! I guess it’s different for everyone but it has way more health benefits than CBD! I’ve been ordering by the case from centurioncbg, this is the best pain relief lotion I’ve ever had. Anyone try them yet? Or any CBG?

Heartland4 days ago

Can someone tell me what type of CBD liquid I’m supposed to put in a vape pen refillable cartridge?

Heartland2 days ago

The new Senate is the most cannabis-friendly in history. Tell your Senators to make this issue a priority!

Heartland5 days ago

Is this fine?

Heartland5 days ago

Mendo x Royal Kush

Heartland2 days ago

Tincture doses?

Heartland2 days ago

Transition from THC to CBD

Heartland5 days ago

Mydecine Innovations Group Included in First-Ever Psychedelics ETF

Heartland3 days ago

pre-made tincture are more expensive?

Uncategorized2 days ago

Auxly Cannabis – The Clear Cut Way To Play Canadian Cannabis 2.0

Heartland4 days ago

What’s wrong with my CBD?

News4 days ago

How Do Vape Pens Work?

Trending

A Cloud Nine Capital Entity Copyright © 2020 – All Rights Reserved Proudly Made in America